GSK links with French venture firm to target rare diseases
LONDON (Reuters) - GlaxoSmithKline is investing 17.5 million euros ($23.5 million) in a new venture fund to invest in drugs for rare...
Read More »
LONDON (Reuters) - GlaxoSmithKline is investing 17.5 million euros ($23.5 million) in a new venture fund to invest in drugs for rare...
Read More »
By Yasmeen Abutaleb WASHINGTON (Reuters) - Four in 10 U.S. adults are now caring for a sick or elderly family member as more people ...
Read More »By Laura Zuckerman (Reuters) - Two of America's premier national parks, Yellowstone and Grand Teton, warned visitors on Wednesday ab...
Read More »By Madeline Will NEW YORK (Reuters) - The American Medical Association joined the effort to discourage consumption of sugary drinks ...
Read More »
By Kate Kelland LONDON (Reuters) - The new Middle East coronavirus that has killed 38 people after emerging late last year is a seri...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - Otherwise healthy people with a diarrhea-causing infection may have picked up the ba...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - Compared to a decade ago, fewer Americans have a cluster of risk factors that togethe...
Read More »By Kerry Grens NEW YORK (Reuters Health) - Prostate removal or radiation therapy to treat cancer is tied to two- to four-fold higher...
Read More »
By Nick Carey CHICAGO (Reuters) - In order to fight what it described as an "obesity epidemic," the American Medical Association vot...
Read More »By Jessica Toonkel and Soyoung Kim NEW YORK (Reuters) - Forest Laboratories Inc, the specialty drugmaker that counts investor Carl I...
Read More »